U.S. Markets open in 9 hrs 20 mins

Iterum Therapeutics plc (ITRM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.5750+0.0388 (+7.24%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 37.1900
52 Week Low 30.4510
50-Day Moving Average 30.6901
200-Day Moving Average 31.2771

Share Statistics

Avg Vol (3 month) 35.61M
Avg Vol (10 day) 31.87M
Shares Outstanding 543.04M
Float 39.73M
% Held by Insiders 11.33%
% Held by Institutions 117.98%
Shares Short (Oct 29, 2020) 4284.51k
Short Ratio (Oct 29, 2020) 40.02
Short % of Float (Oct 29, 2020) 41.02%
Short % of Shares Outstanding (Oct 29, 2020) 40.77%
Shares Short (prior month Sep 29, 2020) 4182.28k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-82.01%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)37k
EBITDA -50.5M
Net Income Avi to Common (ttm)-64.46M
Diluted EPS (ttm)-3.9030
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.9M
Total Cash Per Share (mrq)0.23
Total Debt (mrq)47.56M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.29
Book Value Per Share (mrq)-2.63

Cash Flow Statement

Operating Cash Flow (ttm)-65.51M
Levered Free Cash Flow (ttm)-20.41M